#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1.
1-1	0-2	1.	_	_	_	_

#Text=Introduction
2-1	3-15	Introduction	abstract	new	_	_

#Text=Lipid oxidation is one of the major causes of food deterioration , leading to the loss of nutrients and bioactives , off flavors development , and could also form potentially toxic compounds .
3-1	16-21	Lipid	substance|abstract[3]	new|new[3]	coref|coref	4-20|4-20[21_3]
3-2	22-31	oxidation	abstract[3]	new[3]	_	_
3-3	32-34	is	_	_	_	_
3-4	35-38	one	abstract[4]	new[4]	_	_
3-5	39-41	of	abstract[4]	new[4]	_	_
3-6	42-45	the	abstract[4]|abstract[5]	new[4]|new[5]	_	_
3-7	46-51	major	abstract[4]|abstract[5]	new[4]|new[5]	_	_
3-8	52-58	causes	abstract[4]|abstract[5]	new[4]|new[5]	_	_
3-9	59-61	of	abstract[4]|abstract[5]	new[4]|new[5]	_	_
3-10	62-66	food	abstract[4]|abstract[5]|substance|event[7]	new[4]|new[5]|new|new[7]	coref	10-20
3-11	67-80	deterioration	abstract[4]|abstract[5]|event[7]	new[4]|new[5]|new[7]	_	_
3-12	81-82	,	abstract[4]	new[4]	_	_
3-13	83-90	leading	abstract[4]	new[4]	_	_
3-14	91-93	to	abstract[4]	new[4]	_	_
3-15	94-97	the	abstract[4]|event[8]	new[4]|new[8]	_	_
3-16	98-102	loss	abstract[4]|event[8]	new[4]|new[8]	_	_
3-17	103-105	of	abstract[4]|event[8]	new[4]|new[8]	_	_
3-18	106-115	nutrients	abstract[4]|event[8]|substance	new[4]|new[8]|new	_	_
3-19	116-119	and	abstract[4]|event[8]	new[4]|new[8]	_	_
3-20	120-130	bioactives	abstract[4]|event[8]|substance	new[4]|new[8]|new	_	_
3-21	131-132	,	abstract[4]|event[8]	new[4]|new[8]	_	_
3-22	133-136	off	abstract[4]|event[8]|substance[11]|event[12]	new[4]|new[8]|new[11]|new[12]	coref	8-23[62_11]
3-23	137-144	flavors	abstract[4]|event[8]|substance[11]|event[12]	new[4]|new[8]|new[11]|new[12]	_	_
3-24	145-156	development	abstract[4]|event[8]|event[12]	new[4]|new[8]|new[12]	_	_
3-25	157-158	,	abstract[4]	new[4]	_	_
3-26	159-162	and	abstract[4]	new[4]	_	_
3-27	163-168	could	abstract[4]	new[4]	_	_
3-28	169-173	also	abstract[4]	new[4]	_	_
3-29	174-178	form	abstract[4]|event	new[4]|new	coref|none	16-26[121_0]|3-29[0_121]
3-30	179-190	potentially	abstract[4]|substance[13]	new[4]|new[13]	ana	4-27[0_13]
3-31	191-196	toxic	abstract[4]|substance[13]	new[4]|new[13]	_	_
3-32	197-206	compounds	abstract[4]|substance[13]	new[4]|new[13]	_	_
3-33	207-208	.	_	_	_	_

#Text=The use of synthetic antioxidants , such as butylated hydroxytoluene , butylated hydroxyanisole , or n-propyl gallate to delay lipid oxidation is currently questioned due to their possible harmful effects on human health , and the use of natural antioxidants is of growing interest .
4-1	209-212	The	event[14]	new[14]	_	_
4-2	213-216	use	event[14]	new[14]	_	_
4-3	217-219	of	event[14]	new[14]	_	_
4-4	220-229	synthetic	event[14]|substance[15]	new[14]|new[15]	coref	4-39[26_15]
4-5	230-242	antioxidants	event[14]|substance[15]	new[14]|new[15]	_	_
4-6	243-244	,	event[14]|substance[15]	new[14]|new[15]	_	_
4-7	245-249	such	event[14]|substance[15]	new[14]|new[15]	_	_
4-8	250-252	as	event[14]|substance[15]	new[14]|new[15]	_	_
4-9	253-262	butylated	event[14]|substance[15]|abstract[16]	new[14]|new[15]|new[16]	_	_
4-10	263-277	hydroxytoluene	event[14]|substance[15]|abstract[16]	new[14]|new[15]|new[16]	_	_
4-11	278-279	,	event[14]|substance[15]	new[14]|new[15]	_	_
4-12	280-289	butylated	event[14]|substance[15]|substance[17]	new[14]|new[15]|new[17]	_	_
4-13	290-304	hydroxyanisole	event[14]|substance[15]|substance[17]	new[14]|new[15]|new[17]	_	_
4-14	305-306	,	event[14]|substance[15]	new[14]|new[15]	_	_
4-15	307-309	or	event[14]|substance[15]	new[14]|new[15]	_	_
4-16	310-318	n-propyl	event[14]|substance[15]|abstract|substance[19]	new[14]|new[15]|new|new[19]	_	_
4-17	319-326	gallate	event[14]|substance[15]|substance[19]	new[14]|new[15]|new[19]	_	_
4-18	327-329	to	event[14]|substance[15]|substance[19]	new[14]|new[15]|new[19]	_	_
4-19	330-335	delay	event[14]|substance[15]|substance[19]	new[14]|new[15]|new[19]	_	_
4-20	336-341	lipid	event[14]|substance[15]|substance[19]|substance|abstract[21]	new[14]|new[15]|new[19]|giv|giv[21]	coref|coref	6-9[34_21]|7-27
4-21	342-351	oxidation	event[14]|substance[15]|substance[19]|abstract[21]	new[14]|new[15]|new[19]|giv[21]	_	_
4-22	352-354	is	_	_	_	_
4-23	355-364	currently	_	_	_	_
4-24	365-375	questioned	_	_	_	_
4-25	376-379	due	_	_	_	_
4-26	380-382	to	_	_	_	_
4-27	383-388	their	substance|abstract[23]	giv|new[23]	coref	8-14[59_0]
4-28	389-397	possible	abstract[23]	new[23]	_	_
4-29	398-405	harmful	abstract[23]	new[23]	_	_
4-30	406-413	effects	abstract[23]	new[23]	_	_
4-31	414-416	on	abstract[23]	new[23]	_	_
4-32	417-422	human	abstract[23]|abstract[24]	new[23]|new[24]	_	_
4-33	423-429	health	abstract[23]|abstract[24]	new[23]|new[24]	_	_
4-34	430-431	,	_	_	_	_
4-35	432-435	and	_	_	_	_
4-36	436-439	the	abstract[25]	new[25]	_	_
4-37	440-443	use	abstract[25]	new[25]	_	_
4-38	444-446	of	abstract[25]	new[25]	_	_
4-39	447-454	natural	abstract[25]|substance[26]	new[25]|giv[26]	_	_
4-40	455-467	antioxidants	abstract[25]|substance[26]	new[25]|giv[26]	_	_
4-41	468-470	is	_	_	_	_
4-42	471-473	of	_	_	_	_
4-43	474-481	growing	organization[27]	new[27]	_	_
4-44	482-490	interest	organization[27]	new[27]	_	_
4-45	491-492	.	_	_	_	_

#Text=In recent years , flavonoids have been used to improve the oxidative stability of foods .
5-1	493-495	In	_	_	_	_
5-2	496-502	recent	time[28]	new[28]	_	_
5-3	503-508	years	time[28]	new[28]	_	_
5-4	509-510	,	_	_	_	_
5-5	511-521	flavonoids	substance	new	coref	6-6
5-6	522-526	have	_	_	_	_
5-7	527-531	been	_	_	_	_
5-8	532-536	used	_	_	_	_
5-9	537-539	to	_	_	_	_
5-10	540-547	improve	_	_	_	_
5-11	548-551	the	abstract[30]	new[30]	coref	7-37[53_30]
5-12	552-561	oxidative	abstract[30]	new[30]	_	_
5-13	562-571	stability	abstract[30]	new[30]	_	_
5-14	572-574	of	abstract[30]	new[30]	_	_
5-15	575-580	foods	abstract[30]|substance	new[30]|new	_	_
5-16	581-582	.	_	_	_	_

#Text=The main mechanisms by which flavonoids act against lipid oxidation involve transferring a hydrogen atom or electrons to a peroxyl radical and metal chelation .
6-1	583-586	The	abstract[32]	new[32]	_	_
6-2	587-591	main	abstract[32]	new[32]	_	_
6-3	592-602	mechanisms	abstract[32]	new[32]	_	_
6-4	603-605	by	abstract[32]	new[32]	_	_
6-5	606-611	which	abstract[32]	new[32]	_	_
6-6	612-622	flavonoids	abstract[32]|substance	new[32]|giv	coref	7-1[40_0]
6-7	623-626	act	abstract[32]	new[32]	_	_
6-8	627-634	against	abstract[32]	new[32]	_	_
6-9	635-640	lipid	abstract[32]|abstract[34]	new[32]|giv[34]	_	_
6-10	641-650	oxidation	abstract[32]|abstract[34]	new[32]|giv[34]	_	_
6-11	651-658	involve	_	_	_	_
6-12	659-671	transferring	_	_	_	_
6-13	672-673	a	object[36]	new[36]	_	_
6-14	674-682	hydrogen	substance|object[36]	new|new[36]	_	_
6-15	683-687	atom	object[36]	new[36]	_	_
6-16	688-690	or	_	_	_	_
6-17	691-700	electrons	substance	new	_	_
6-18	701-703	to	_	_	_	_
6-19	704-705	a	_	_	_	_
6-20	706-713	peroxyl	_	_	_	_
6-21	714-721	radical	_	_	_	_
6-22	722-725	and	_	_	_	_
6-23	726-731	metal	substance|object[39]	new|new[39]	_	_
6-24	732-741	chelation	object[39]	new[39]	_	_
6-25	742-743	.	_	_	_	_

#Text=Free flavonoids , mainly quercetin , myricetin , morin , ( +)catechin , ( −)epigallocatechin , ( −)epicatechin , and kaempferol have been incorporated in different lipid systems with varying degrees of success in terms of oxidative stability .
7-1	744-748	Free	substance[40]	giv[40]	appos	7-4[42_40]
7-2	749-759	flavonoids	substance[40]	giv[40]	_	_
7-3	760-761	,	_	_	_	_
7-4	762-768	mainly	plant[41]|substance[42]	new[41]|giv[42]	appos|coref	7-9[0_42]|20-13[0_41]
7-5	769-778	quercetin	plant[41]|substance[42]	new[41]|giv[42]	_	_
7-6	779-780	,	substance[42]	giv[42]	_	_
7-7	781-790	myricetin	substance[42]|animal	giv[42]|new	_	_
7-8	791-792	,	substance[42]	giv[42]	_	_
7-9	793-798	morin	substance[42]|substance	giv[42]|giv	appos	7-21
7-10	799-800	,	substance[42]	giv[42]	_	_
7-11	801-802	(	substance[42]	giv[42]	_	_
7-12	803-813	+)catechin	substance[42]|person	giv[42]|new	_	_
7-13	814-815	,	substance[42]	giv[42]	_	_
7-14	816-817	(	substance[42]	giv[42]	_	_
7-15	818-836	−)epigallocatechin	substance[42]|abstract	giv[42]|new	_	_
7-16	837-838	,	substance[42]	giv[42]	_	_
7-17	839-840	(	substance[42]	giv[42]	_	_
7-18	841-854	−)epicatechin	substance[42]|abstract	giv[42]|new	_	_
7-19	855-856	,	substance[42]	giv[42]	_	_
7-20	857-860	and	substance[42]	giv[42]	_	_
7-21	861-871	kaempferol	substance[42]|substance	giv[42]|giv	coref	8-4[55_0]
7-22	872-876	have	_	_	_	_
7-23	877-881	been	_	_	_	_
7-24	882-894	incorporated	_	_	_	_
7-25	895-897	in	_	_	_	_
7-26	898-907	different	abstract[50]	new[50]	coref	8-7[57_50]
7-27	908-913	lipid	substance|abstract[50]	giv|new[50]	coref	8-7
7-28	914-921	systems	abstract[50]	new[50]	_	_
7-29	922-926	with	_	_	_	_
7-30	927-934	varying	abstract[51]	new[51]	_	_
7-31	935-942	degrees	abstract[51]	new[51]	_	_
7-32	943-945	of	abstract[51]	new[51]	_	_
7-33	946-953	success	abstract[51]|abstract[52]	new[51]|new[52]	_	_
7-34	954-956	in	abstract[51]|abstract[52]	new[51]|new[52]	_	_
7-35	957-962	terms	abstract[51]|abstract[52]	new[51]|new[52]	_	_
7-36	963-965	of	abstract[51]|abstract[52]	new[51]|new[52]	_	_
7-37	966-975	oxidative	abstract[51]|abstract[52]|abstract[53]	new[51]|new[52]|giv[53]	coref	8-21[0_53]
7-38	976-985	stability	abstract[51]|abstract[52]|abstract[53]	new[51]|new[52]|giv[53]	_	_
7-39	986-987	.	_	_	_	_

#Text=The incorporation of free flavonoids in lipid systems may have some drawbacks since these phenolic compounds have limited solubility and stability , together with unpleasant flavors in some cases .
8-1	988-991	The	event[54]	new[54]	_	_
8-2	992-1005	incorporation	event[54]	new[54]	_	_
8-3	1006-1008	of	event[54]	new[54]	_	_
8-4	1009-1013	free	event[54]|substance[55]	new[54]|giv[55]	coref	9-3[0_55]
8-5	1014-1024	flavonoids	event[54]|substance[55]	new[54]|giv[55]	_	_
8-6	1025-1027	in	event[54]	new[54]	_	_
8-7	1028-1033	lipid	event[54]|substance|abstract[57]	new[54]|giv|giv[57]	coref|coref	14-22|14-22[105_57]
8-8	1034-1041	systems	event[54]|abstract[57]	new[54]|giv[57]	_	_
8-9	1042-1045	may	_	_	_	_
8-10	1046-1050	have	_	_	_	_
8-11	1051-1055	some	abstract[58]	new[58]	_	_
8-12	1056-1065	drawbacks	abstract[58]	new[58]	_	_
8-13	1066-1071	since	_	_	_	_
8-14	1072-1077	these	substance[59]	giv[59]	coref	10-16[73_59]
8-15	1078-1086	phenolic	substance[59]	giv[59]	_	_
8-16	1087-1096	compounds	substance[59]	giv[59]	_	_
8-17	1097-1101	have	_	_	_	_
8-18	1102-1109	limited	substance[60]	new[60]	_	_
8-19	1110-1120	solubility	substance[60]	new[60]	_	_
8-20	1121-1124	and	_	_	_	_
8-21	1125-1134	stability	abstract	giv	_	_
8-22	1135-1136	,	_	_	_	_
8-23	1137-1145	together	substance[62]	giv[62]	_	_
8-24	1146-1150	with	substance[62]	giv[62]	_	_
8-25	1151-1161	unpleasant	substance[62]	giv[62]	_	_
8-26	1162-1169	flavors	substance[62]	giv[62]	_	_
8-27	1170-1172	in	substance[62]	giv[62]	_	_
8-28	1173-1177	some	substance[62]|abstract[63]	giv[62]|new[63]	_	_
8-29	1178-1183	cases	substance[62]|abstract[63]	giv[62]|new[63]	_	_
8-30	1184-1185	.	_	_	_	_

#Text=Encapsulation of flavonoids is a technology which could enhance the stability of flavonoids .
9-1	1186-1199	Encapsulation	abstract[64]	new[64]	coref	9-5[66_64]
9-2	1200-1202	of	abstract[64]	new[64]	_	_
9-3	1203-1213	flavonoids	abstract[64]|substance	new[64]|giv	coref	9-13
9-4	1214-1216	is	_	_	_	_
9-5	1217-1218	a	abstract[66]	giv[66]	coref	10-3[0_66]
9-6	1219-1229	technology	abstract[66]	giv[66]	_	_
9-7	1230-1235	which	abstract[66]	giv[66]	_	_
9-8	1236-1241	could	abstract[66]	giv[66]	_	_
9-9	1242-1249	enhance	abstract[66]	giv[66]	_	_
9-10	1250-1253	the	abstract[66]|abstract[67]	giv[66]|new[67]	_	_
9-11	1254-1263	stability	abstract[66]|abstract[67]	giv[66]|new[67]	_	_
9-12	1264-1266	of	abstract[66]|abstract[67]	giv[66]|new[67]	_	_
9-13	1267-1277	flavonoids	abstract[66]|abstract[67]|substance	giv[66]|new[67]|giv	coref	14-15[102_0]
9-14	1278-1279	.	_	_	_	_

#Text=Among the encapsulation methods , spray-drying is the most widely used for the encapsulation of bioactive compounds in the food industry .
10-1	1280-1285	Among	_	_	_	_
10-2	1286-1289	the	abstract[70]	new[70]	_	_
10-3	1290-1303	encapsulation	abstract|abstract[70]	giv|new[70]	_	_
10-4	1304-1311	methods	abstract[70]	new[70]	_	_
10-5	1312-1313	,	_	_	_	_
10-6	1314-1326	spray-drying	abstract	new	coref	17-7
10-7	1327-1329	is	_	_	_	_
10-8	1330-1333	the	_	_	_	_
10-9	1334-1338	most	_	_	_	_
10-10	1339-1345	widely	_	_	_	_
10-11	1346-1350	used	_	_	_	_
10-12	1351-1354	for	_	_	_	_
10-13	1355-1358	the	abstract[72]	new[72]	_	_
10-14	1359-1372	encapsulation	abstract[72]	new[72]	_	_
10-15	1373-1375	of	abstract[72]	new[72]	_	_
10-16	1376-1385	bioactive	abstract[72]|substance[73]	new[72]|giv[73]	_	_
10-17	1386-1395	compounds	abstract[72]|substance[73]	new[72]|giv[73]	_	_
10-18	1396-1398	in	abstract[72]|substance[73]	new[72]|giv[73]	_	_
10-19	1399-1402	the	abstract[72]|substance[73]|abstract[75]	new[72]|giv[73]|new[75]	_	_
10-20	1403-1407	food	abstract[72]|substance[73]|substance|abstract[75]	new[72]|giv[73]|giv|new[75]	_	_
10-21	1408-1416	industry	abstract[72]|substance[73]|abstract[75]	new[72]|giv[73]|new[75]	_	_
10-22	1417-1418	.	_	_	_	_

#Text=Inulin is a linear fructo-oligosaccharide composed of fructosyl units ( β ( 2→1 ) linkage ) and usually contains one terminal glucose moiety per molecule .
11-1	1419-1425	Inulin	substance	new	coref	11-3[77_0]
11-2	1426-1428	is	_	_	_	_
11-3	1429-1430	a	substance[77]	giv[77]	coref	12-3[0_77]
11-4	1431-1437	linear	substance[77]	giv[77]	_	_
11-5	1438-1460	fructo-oligosaccharide	substance[77]	giv[77]	_	_
11-6	1461-1469	composed	substance[77]	giv[77]	_	_
11-7	1470-1472	of	substance[77]	giv[77]	_	_
11-8	1473-1482	fructosyl	substance[77]|organization[78]	giv[77]|new[78]	_	_
11-9	1483-1488	units	substance[77]|organization[78]	giv[77]|new[78]	_	_
11-10	1489-1490	(	object[80]	new[80]	ana	13-8[0_80]
11-11	1491-1492	β	abstract[79]|object[80]	new[79]|new[80]	_	_
11-12	1493-1494	(	abstract[79]|object[80]	new[79]|new[80]	_	_
11-13	1495-1498	2→1	abstract[79]|object[80]	new[79]|new[80]	_	_
11-14	1499-1500	)	abstract[79]|object[80]	new[79]|new[80]	_	_
11-15	1501-1508	linkage	object[80]	new[80]	_	_
11-16	1509-1510	)	object[80]	new[80]	_	_
11-17	1511-1514	and	_	_	_	_
11-18	1515-1522	usually	_	_	_	_
11-19	1523-1531	contains	_	_	_	_
11-20	1532-1535	one	abstract[82]	new[82]	_	_
11-21	1536-1544	terminal	abstract[82]	new[82]	_	_
11-22	1545-1552	glucose	substance|abstract[82]	new|new[82]	_	_
11-23	1553-1559	moiety	abstract[82]	new[82]	_	_
11-24	1560-1563	per	abstract[82]	new[82]	_	_
11-25	1564-1572	molecule	abstract[82]|substance	new[82]|new	_	_
11-26	1573-1574	.	_	_	_	_

#Text=β-linkage makes inulin resistant to hydrolysis by human gastrointestinal enzymes and it is classified as colonic delivery biopolymer .
12-1	1575-1584	β-linkage	substance	new	_	_
12-2	1585-1590	makes	_	_	_	_
12-3	1591-1597	inulin	substance	giv	coref	13-2
12-4	1598-1607	resistant	_	_	_	_
12-5	1608-1610	to	_	_	_	_
12-6	1611-1621	hydrolysis	abstract	new	ana	12-12
12-7	1622-1624	by	_	_	_	_
12-8	1625-1630	human	substance[87]	new[87]	_	_
12-9	1631-1647	gastrointestinal	substance[87]	new[87]	_	_
12-10	1648-1655	enzymes	substance[87]	new[87]	_	_
12-11	1656-1659	and	_	_	_	_
12-12	1660-1662	it	abstract	giv	_	_
12-13	1663-1665	is	_	_	_	_
12-14	1666-1676	classified	_	_	_	_
12-15	1677-1679	as	_	_	_	_
12-16	1680-1687	colonic	abstract[89]|abstract[90]	new[89]|new[90]	_	_
12-17	1688-1696	delivery	abstract[89]|abstract[90]	new[89]|new[90]	_	_
12-18	1697-1707	biopolymer	abstract[90]	new[90]	_	_
12-19	1708-1709	.	_	_	_	_

#Text=Although inulin is moderately water soluble , it is used as an encapsulating agent by spray drying due to low viscosity and colorless solutions .
13-1	1710-1718	Although	_	_	_	_
13-2	1719-1725	inulin	substance	giv	coref	15-14
13-3	1726-1728	is	_	_	_	_
13-4	1729-1739	moderately	_	_	_	_
13-5	1740-1745	water	substance	new	_	_
13-6	1746-1753	soluble	_	_	_	_
13-7	1754-1755	,	_	_	_	_
13-8	1756-1758	it	object	giv	_	_
13-9	1759-1761	is	_	_	_	_
13-10	1762-1766	used	_	_	_	_
13-11	1767-1769	as	_	_	_	_
13-12	1770-1772	an	substance[94]	new[94]	coref	20-19[156_94]
13-13	1773-1786	encapsulating	substance[94]	new[94]	_	_
13-14	1787-1792	agent	substance[94]	new[94]	_	_
13-15	1793-1795	by	_	_	_	_
13-16	1796-1801	spray	object|event[96]	new|new[96]	_	_
13-17	1802-1808	drying	event[96]	new[96]	_	_
13-18	1809-1812	due	_	_	_	_
13-19	1813-1815	to	_	_	_	_
13-20	1816-1819	low	abstract[97]	new[97]	_	_
13-21	1820-1829	viscosity	abstract[97]	new[97]	_	_
13-22	1830-1833	and	_	_	_	_
13-23	1834-1843	colorless	substance[98]	new[98]	_	_
13-24	1844-1853	solutions	substance[98]	new[98]	_	_
13-25	1854-1855	.	_	_	_	_

#Text=However , there are few studies focused on the effect of the incorporation of microencapsulated flavonoids on the oxidative stability of lipid systems .
14-1	1856-1863	However	_	_	_	_
14-2	1864-1865	,	_	_	_	_
14-3	1866-1871	there	_	_	_	_
14-4	1872-1875	are	_	_	_	_
14-5	1876-1879	few	abstract[99]	new[99]	coref	15-2[106_99]
14-6	1880-1887	studies	abstract[99]	new[99]	_	_
14-7	1888-1895	focused	abstract[99]	new[99]	_	_
14-8	1896-1898	on	abstract[99]	new[99]	_	_
14-9	1899-1902	the	abstract[99]|abstract[100]	new[99]|new[100]	_	_
14-10	1903-1909	effect	abstract[99]|abstract[100]	new[99]|new[100]	_	_
14-11	1910-1912	of	abstract[99]|abstract[100]	new[99]|new[100]	_	_
14-12	1913-1916	the	abstract[99]|abstract[100]|event[101]	new[99]|new[100]|new[101]	_	_
14-13	1917-1930	incorporation	abstract[99]|abstract[100]|event[101]	new[99]|new[100]|new[101]	_	_
14-14	1931-1933	of	abstract[99]|abstract[100]|event[101]	new[99]|new[100]|new[101]	_	_
14-15	1934-1951	microencapsulated	abstract[99]|abstract[100]|event[101]|substance[102]	new[99]|new[100]|new[101]|giv[102]	coref	15-10[0_102]
14-16	1952-1962	flavonoids	abstract[99]|abstract[100]|event[101]|substance[102]	new[99]|new[100]|new[101]|giv[102]	_	_
14-17	1963-1965	on	abstract[99]|abstract[100]	new[99]|new[100]	_	_
14-18	1966-1969	the	abstract[99]|abstract[100]|abstract[103]	new[99]|new[100]|new[103]	coref	20-38[161_103]
14-19	1970-1979	oxidative	abstract[99]|abstract[100]|abstract[103]	new[99]|new[100]|new[103]	_	_
14-20	1980-1989	stability	abstract[99]|abstract[100]|abstract[103]	new[99]|new[100]|new[103]	_	_
14-21	1990-1992	of	abstract[99]|abstract[100]|abstract[103]	new[99]|new[100]|new[103]	_	_
14-22	1993-1998	lipid	abstract[99]|abstract[100]|abstract[103]|substance|abstract[105]	new[99]|new[100]|new[103]|giv|giv[105]	coref|coref	20-42|20-42[163_105]
14-23	1999-2006	systems	abstract[99]|abstract[100]|abstract[103]|abstract[105]	new[99]|new[100]|new[103]|giv[105]	_	_
14-24	2007-2008	.	_	_	_	_

#Text=In previous studies undertaken by our research group , flavonoids were microencapsulated with inulin ( lipid-insoluble polymer ) , where channelizing agents ( lipid-soluble polymer ) were incorporated .
15-1	2009-2011	In	_	_	_	_
15-2	2012-2020	previous	abstract[106]	giv[106]	_	_
15-3	2021-2028	studies	abstract[106]	giv[106]	_	_
15-4	2029-2039	undertaken	abstract[106]	giv[106]	_	_
15-5	2040-2042	by	abstract[106]	giv[106]	_	_
15-6	2043-2046	our	abstract[106]|person|person[108]	giv[106]|acc|new[108]	_	_
15-7	2047-2055	research	abstract[106]|person[108]	giv[106]|new[108]	_	_
15-8	2056-2061	group	abstract[106]|person[108]	giv[106]|new[108]	_	_
15-9	2062-2063	,	_	_	_	_
15-10	2064-2074	flavonoids	substance	giv	coref	16-7[115_0]
15-11	2075-2079	were	_	_	_	_
15-12	2080-2097	microencapsulated	_	_	_	_
15-13	2098-2102	with	_	_	_	_
15-14	2103-2109	inulin	substance	giv	appos	15-16[111_0]
15-15	2110-2111	(	_	_	_	_
15-16	2112-2127	lipid-insoluble	substance[111]	giv[111]	coref	18-7[0_111]
15-17	2128-2135	polymer	substance[111]	giv[111]	_	_
15-18	2136-2137	)	_	_	_	_
15-19	2138-2139	,	_	_	_	_
15-20	2140-2145	where	_	_	_	_
15-21	2146-2158	channelizing	substance[112]	new[112]	appos	15-24[113_112]
15-22	2159-2165	agents	substance[112]	new[112]	_	_
15-23	2166-2167	(	_	_	_	_
15-24	2168-2181	lipid-soluble	substance[113]	giv[113]	_	_
15-25	2182-2189	polymer	substance[113]	giv[113]	_	_
15-26	2190-2191	)	_	_	_	_
15-27	2192-2196	were	_	_	_	_
15-28	2197-2209	incorporated	_	_	_	_
15-29	2210-2211	.	_	_	_	_

#Text=These microparticles were able to release the encapsulated flavonoids and improve the oxidative stability of methyl linoleate and vegetable oils , which was attributed to the formation of channels inside the microparticles , favoring the diffusion of flavonoids .
16-1	2212-2217	These	plant[114]	new[114]	coref	16-31[123_114]
16-2	2218-2232	microparticles	plant[114]	new[114]	_	_
16-3	2233-2237	were	_	_	_	_
16-4	2238-2242	able	_	_	_	_
16-5	2243-2245	to	_	_	_	_
16-6	2246-2253	release	_	_	_	_
16-7	2254-2257	the	substance[115]	giv[115]	coref	16-38[0_115]
16-8	2258-2270	encapsulated	substance[115]	giv[115]	_	_
16-9	2271-2281	flavonoids	substance[115]	giv[115]	_	_
16-10	2282-2285	and	_	_	_	_
16-11	2286-2293	improve	_	_	_	_
16-12	2294-2297	the	abstract[116]	new[116]	_	_
16-13	2298-2307	oxidative	abstract[116]	new[116]	_	_
16-14	2308-2317	stability	abstract[116]	new[116]	_	_
16-15	2318-2320	of	abstract[116]	new[116]	_	_
16-16	2321-2327	methyl	abstract[116]|abstract|substance[118]	new[116]|new|new[118]	_	_
16-17	2328-2337	linoleate	abstract[116]|substance[118]	new[116]|new[118]	_	_
16-18	2338-2341	and	abstract[116]	new[116]	_	_
16-19	2342-2351	vegetable	abstract[116]|plant|substance[120]	new[116]|new|new[120]	_	_
16-20	2352-2356	oils	abstract[116]|substance[120]	new[116]|new[120]	_	_
16-21	2357-2358	,	abstract[116]	new[116]	_	_
16-22	2359-2364	which	abstract[116]	new[116]	_	_
16-23	2365-2368	was	abstract[116]	new[116]	_	_
16-24	2369-2379	attributed	abstract[116]	new[116]	_	_
16-25	2380-2382	to	abstract[116]	new[116]	_	_
16-26	2383-2386	the	abstract[116]|event[121]	new[116]|new[121]	_	_
16-27	2387-2396	formation	abstract[116]|event[121]	new[116]|new[121]	_	_
16-28	2397-2399	of	abstract[116]|event[121]	new[116]|new[121]	_	_
16-29	2400-2408	channels	abstract[116]|event[121]|place[122]	new[116]|new[121]|new[122]	_	_
16-30	2409-2415	inside	abstract[116]|event[121]|place[122]	new[116]|new[121]|new[122]	_	_
16-31	2416-2419	the	abstract[116]|event[121]|place[122]|plant[123]	new[116]|new[121]|new[122]|giv[123]	coref	18-35[140_123]
16-32	2420-2434	microparticles	abstract[116]|event[121]|place[122]|plant[123]	new[116]|new[121]|new[122]|giv[123]	_	_
16-33	2435-2436	,	_	_	_	_
16-34	2437-2445	favoring	_	_	_	_
16-35	2446-2449	the	event[124]	new[124]	_	_
16-36	2450-2459	diffusion	event[124]	new[124]	_	_
16-37	2460-2462	of	event[124]	new[124]	_	_
16-38	2463-2473	flavonoids	event[124]|substance	new[124]|giv	coref	20-9
16-39	2474-2475	.	_	_	_	_

#Text=In general , powders obtained by spray-drying are amorphous .
17-1	2476-2478	In	_	_	_	_
17-2	2479-2486	general	_	_	_	_
17-3	2487-2488	,	_	_	_	_
17-4	2489-2496	powders	substance[126]	new[126]	_	_
17-5	2497-2505	obtained	substance[126]	new[126]	_	_
17-6	2506-2508	by	substance[126]	new[126]	_	_
17-7	2509-2521	spray-drying	substance[126]|abstract	new[126]|giv	coref	18-12
17-8	2522-2525	are	_	_	_	_
17-9	2526-2535	amorphous	_	_	_	_
17-10	2536-2537	.	_	_	_	_

#Text=However , in the case of inulin , process variables of spray-drying such as feed temperature and inlet air temperature have been reported to influence both the morphology and the degree of crystallinity of the microparticles .
18-1	2538-2545	However	_	_	_	_
18-2	2546-2547	,	_	_	_	_
18-3	2548-2550	in	_	_	_	_
18-4	2551-2554	the	abstract[128]	new[128]	_	_
18-5	2555-2559	case	abstract[128]	new[128]	_	_
18-6	2560-2562	of	abstract[128]	new[128]	_	_
18-7	2563-2569	inulin	abstract[128]|substance	new[128]|giv	coref	20-17[155_0]
18-8	2570-2571	,	_	_	_	_
18-9	2572-2579	process	abstract|abstract[131]	new|new[131]	_	_
18-10	2580-2589	variables	abstract[131]	new[131]	_	_
18-11	2590-2592	of	abstract[131]	new[131]	_	_
18-12	2593-2605	spray-drying	abstract[131]|abstract	new[131]|giv	_	_
18-13	2606-2610	such	abstract[131]	new[131]	_	_
18-14	2611-2613	as	abstract[131]	new[131]	_	_
18-15	2614-2618	feed	abstract[131]|substance|abstract[134]	new[131]|new|new[134]	_	_
18-16	2619-2630	temperature	abstract[131]|abstract[134]	new[131]|new[134]	_	_
18-17	2631-2634	and	abstract[131]	new[131]	_	_
18-18	2635-2640	inlet	abstract[131]|abstract[136]	new[131]|new[136]	_	_
18-19	2641-2644	air	abstract[131]|substance|abstract[136]	new[131]|new|new[136]	_	_
18-20	2645-2656	temperature	abstract[131]|abstract[136]	new[131]|new[136]	_	_
18-21	2657-2661	have	_	_	_	_
18-22	2662-2666	been	_	_	_	_
18-23	2667-2675	reported	_	_	_	_
18-24	2676-2678	to	_	_	_	_
18-25	2679-2688	influence	abstract	new	none|none	18-25[0_157]|19-22
18-26	2689-2693	both	abstract[137]	new[137]	_	_
18-27	2694-2697	the	abstract[137]	new[137]	_	_
18-28	2698-2708	morphology	abstract[137]	new[137]	_	_
18-29	2709-2712	and	_	_	_	_
18-30	2713-2716	the	abstract[138]	new[138]	_	_
18-31	2717-2723	degree	abstract[138]	new[138]	_	_
18-32	2724-2726	of	abstract[138]	new[138]	_	_
18-33	2727-2740	crystallinity	abstract[138]|abstract[139]	new[138]|new[139]	_	_
18-34	2741-2743	of	abstract[138]|abstract[139]	new[138]|new[139]	_	_
18-35	2744-2747	the	abstract[138]|abstract[139]|plant[140]	new[138]|new[139]|giv[140]	coref	19-2[141_140]
18-36	2748-2762	microparticles	abstract[138]|abstract[139]|plant[140]	new[138]|new[139]|giv[140]	_	_
18-37	2763-2764	.	_	_	_	_

#Text=When the flavonoid-inulin microparticles are incorporated into a lipid system , the physical state of these microparticles ( semi-crystalline/amorphous ) may influence the oxidative stability of the system , but this still has not been addressed .
19-1	2765-2769	When	_	_	_	_
19-2	2770-2773	the	plant[141]	giv[141]	coref	19-16[144_141]
19-3	2774-2790	flavonoid-inulin	plant[141]	giv[141]	_	_
19-4	2791-2805	microparticles	plant[141]	giv[141]	_	_
19-5	2806-2809	are	_	_	_	_
19-6	2810-2822	incorporated	_	_	_	_
19-7	2823-2827	into	_	_	_	_
19-8	2828-2829	a	abstract[142]	new[142]	coref	19-27[146_142]
19-9	2830-2835	lipid	abstract[142]	new[142]	_	_
19-10	2836-2842	system	abstract[142]	new[142]	_	_
19-11	2843-2844	,	_	_	_	_
19-12	2845-2848	the	abstract[143]	new[143]	_	_
19-13	2849-2857	physical	abstract[143]	new[143]	_	_
19-14	2858-2863	state	abstract[143]	new[143]	_	_
19-15	2864-2866	of	abstract[143]	new[143]	_	_
19-16	2867-2872	these	abstract[143]|plant[144]	new[143]|giv[144]	coref	20-9[154_144]
19-17	2873-2887	microparticles	abstract[143]|plant[144]	new[143]|giv[144]	_	_
19-18	2888-2889	(	_	_	_	_
19-19	2890-2916	semi-crystalline/amorphous	_	_	_	_
19-20	2917-2918	)	_	_	_	_
19-21	2919-2922	may	_	_	_	_
19-22	2923-2932	influence	abstract	new	coref	20-24[157_0]
19-23	2933-2936	the	abstract[145]	new[145]	_	_
19-24	2937-2946	oxidative	abstract[145]	new[145]	_	_
19-25	2947-2956	stability	abstract[145]	new[145]	_	_
19-26	2957-2959	of	abstract[145]	new[145]	_	_
19-27	2960-2963	the	abstract[145]|abstract[146]	new[145]|giv[146]	ana	19-31[0_146]
19-28	2964-2970	system	abstract[145]|abstract[146]	new[145]|giv[146]	_	_
19-29	2971-2972	,	_	_	_	_
19-30	2973-2976	but	_	_	_	_
19-31	2977-2981	this	abstract	giv	_	_
19-32	2982-2987	still	_	_	_	_
19-33	2988-2991	has	_	_	_	_
19-34	2992-2995	not	_	_	_	_
19-35	2996-3000	been	_	_	_	_
19-36	3001-3010	addressed	_	_	_	_
19-37	3011-3012	.	_	_	_	_

#Text=The objective of this research was to design flavonoids ( epicatechin and quercetin ) microparticles with inulin as encapsulating agent and to evaluate the influence of the physical state of spray-dried flavonoid microparticles ( semi-crystalline/amorphous ) on the oxidative stability of lipid systems .
20-1	3013-3016	The	abstract[148]	new[148]	_	_
20-2	3017-3026	objective	abstract[148]	new[148]	_	_
20-3	3027-3029	of	abstract[148]	new[148]	_	_
20-4	3030-3034	this	abstract[148]|abstract[149]	new[148]|new[149]	_	_
20-5	3035-3043	research	abstract[148]|abstract[149]	new[148]|new[149]	_	_
20-6	3044-3047	was	_	_	_	_
20-7	3048-3050	to	_	_	_	_
20-8	3051-3057	design	_	_	_	_
20-9	3058-3068	flavonoids	substance|plant[154]	giv|giv[154]	appos|coref	20-11[152_0]|20-31[160_154]
20-10	3069-3070	(	plant[154]	giv[154]	_	_
20-11	3071-3082	epicatechin	person|substance[152]|plant[154]	new|giv[152]|giv[154]	_	_
20-12	3083-3086	and	substance[152]|plant[154]	giv[152]|giv[154]	_	_
20-13	3087-3096	quercetin	substance[152]|plant|plant[154]	giv[152]|giv|giv[154]	_	_
20-14	3097-3098	)	plant[154]	giv[154]	_	_
20-15	3099-3113	microparticles	plant[154]	giv[154]	_	_
20-16	3114-3118	with	plant[154]	giv[154]	_	_
20-17	3119-3125	inulin	plant[154]|substance[155]	giv[154]|giv[155]	_	_
20-18	3126-3128	as	plant[154]|substance[155]	giv[154]|giv[155]	_	_
20-19	3129-3142	encapsulating	plant[154]|substance[155]|substance[156]	giv[154]|giv[155]|giv[156]	_	_
20-20	3143-3148	agent	plant[154]|substance[155]|substance[156]	giv[154]|giv[155]|giv[156]	_	_
20-21	3149-3152	and	_	_	_	_
20-22	3153-3155	to	_	_	_	_
20-23	3156-3164	evaluate	_	_	_	_
20-24	3165-3168	the	abstract[157]	new[157]	_	_
20-25	3169-3178	influence	abstract[157]	new[157]	_	_
20-26	3179-3181	of	abstract[157]	new[157]	_	_
20-27	3182-3185	the	abstract[157]|abstract[158]	new[157]|new[158]	_	_
20-28	3186-3194	physical	abstract[157]|abstract[158]	new[157]|new[158]	_	_
20-29	3195-3200	state	abstract[157]|abstract[158]	new[157]|new[158]	_	_
20-30	3201-3203	of	abstract[157]|abstract[158]	new[157]|new[158]	_	_
20-31	3204-3215	spray-dried	abstract[157]|abstract[158]|plant[160]	new[157]|new[158]|giv[160]	_	_
20-32	3216-3225	flavonoid	abstract[157]|abstract[158]|substance|plant[160]	new[157]|new[158]|new|giv[160]	_	_
20-33	3226-3240	microparticles	abstract[157]|abstract[158]|plant[160]	new[157]|new[158]|giv[160]	_	_
20-34	3241-3242	(	_	_	_	_
20-35	3243-3269	semi-crystalline/amorphous	_	_	_	_
20-36	3270-3271	)	_	_	_	_
20-37	3272-3274	on	_	_	_	_
20-38	3275-3278	the	abstract[161]	giv[161]	_	_
20-39	3279-3288	oxidative	abstract[161]	giv[161]	_	_
20-40	3289-3298	stability	abstract[161]	giv[161]	_	_
20-41	3299-3301	of	abstract[161]	giv[161]	_	_
20-42	3302-3307	lipid	abstract[161]|substance|abstract[163]	giv[161]|giv|giv[163]	_	_
20-43	3308-3315	systems	abstract[161]|abstract[163]	giv[161]|giv[163]	_	_
20-44	3316-3317	.	_	_	_	_
